Journal - Endocrine, Metabolic & Immune Disorders - Drug Targets

Impact Factor

Current: 2
5 - Year: 2.2

Ranking & Category

110th of 143 in Endocrinology & Metabolism
126th of 155 in Immunology
172nd of 261 in Pharmacology & Pharmacy

Topic(s) Covered

6 Topic(s)

View

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

This journal is devoted to full-length/ mini-reviews and original articles based on experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiome composition are welcome. The journal’s scope also covers neuroendocrinology, reproductive endocrinology, hormone secretion, and their effects on different organs.

Abstracted & Indexed in:

BIOSIS Previews BIOSIS Reviews Reports and Meetings British Library Cabell's Directory/Journalytics Cambridge Scientific Abstracts (CSA)/ProQuest Chemical Abstracts Service/SciFinder CNKI Scholar EBSCO EMBASE EMBiology ERA 2018 Essential Science Indicators Genamics Journal Seek Google Scholar Index Medicus J-Gate JournalTOCs MediaFinder®-Standard Periodical Directory MEDLINE/PubMed Norwegian Register OpenAire PubsHub QOAM Science Citation Index Expanded™ (SciSearch®) ScienceGate Scilit Scopus Suweco CZ Ulrich's Periodicals Directory

Archiving and Copyright:

Portico Sherpa Romeo

Journal Database:

Dimensions

Society Accreditation

The Official Journal of Associazione Medici Endocrinologi

COPE Compliant

Archived in

Special Offers

New eBook

Immune Response to Parasitic Infections: Immunity to Helminths and Novel Therapeutic Approaches
You can view the contents of this
eBook [here] .

Endorsement(s)

"EMID-DT is a prestigious journal with a multidisciplinary coverage. Its aim is to provide cutting- edge information to readers working in different field of research ranging from immune endocrine to metabolic disorders."

Chris Galanos
Max Planck Institude, Germany